Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma by Joyce K. Thompson, Filip Bednar

Get full text

3373 Modulation of Hedgehog Signaling Alters Immune Infiltration in Pancreatic Cancer by Nina Steele, Valerie Irizarry-Negron, Veerin Sirihorachai, Samantha Kemp, Eileen Carpenter, Christopher Halbrook, Costas Lyssiotis, Filip Bednar, Timothy Frankel, Benjamin Allen, Marina Pasca di Magliano

Get full text

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer by Rishi Das, MD, MPH, Madeline R. Abbott, MS, Scott W. Hadley, PhD, Vaibhav Sahai, MBBS, MS, Filip Bednar, MD, PhD, Joseph R. Evans, MD, PhD, Matthew J. Schipper, PhD, Theodore S. Lawrence, MD, Kyle C. Cuneo, MD

Get full text

Arginase 1 is a key driver of immune suppression in pancreatic cancer by Rosa E Menjivar, Zeribe C Nwosu, Wenting Du, Katelyn L Donahue, Hanna S Hong, Carlos Espinoza, Kristee Brown, Ashley Velez-Delgado, Wei Yan, Fatima Lima, Allison Bischoff, Padma Kadiyala, Daniel Salas-Escabillas, Howard C Crawford, Filip Bednar, Eileen Carpenter, Yaqing Zhang, Christopher J Halbrook, Costas A Lyssiotis, Marina Pasca di Magliano

Get full text

Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. by Michael K Scales, Ashley Velez-Delgado, Nina G Steele, Hannah E Schrader, Anna M Stabnick, Wei Yan, Nayanna M Mercado Soto, Zeribe C Nwosu, Craig Johnson, Yaqing Zhang, Daniel J Salas-Escabillas, Rosa E Menjivar, H Carlo Maurer, Howard C Crawford, Filip Bednar, Kenneth P Olive, Marina Pasca di Magliano, Benjamin L Allen

Get full text